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C-Reactive Protein (CRP) levels in neonatal
meningitis in England: an analysis of
national variations in CRP cut-offs for
lumbar puncture
Jonathan P. Sturgeon* , Beatrice Zanetti and Dwight Lindo
Abstract
Background: Recent National Institute for Health and Care Excellence (NICE) CG149 guidelines suggest considering
performing a lumbar puncture (LP) to investigate for meningitis in early-onset sepsis in a neonate when a C-
reactive protein (CRP) level >10mg/L, but the evidence for this recommendation is poorly defined.
Methods: Data on trust-wide LP protocols, neonatal meningitis incidence, lumbar punctures, and CRP levels seen in
cases of neonatal meningitis were asked of all 137 trusts in England that recorded a birth in 2017. Our local
Kingston Hospital data on every LP performed was obtained to estimate the specificity of CRP rises.
Results: 73/123 (59.3%) of trusts follow the NICE CG149 recommendation of considering an LP if the CRP >10mg/L.
The national incidence of neonatal meningitis was 0.467/1,000 births, and an LP was performed in 1.37% of all
babies, which was significantly higher in trusts considering the CRP > 10mg/L cut-off. A CRP > 10mg/L cut-off
sensitivity was 88.9% based on the highest CRP level 4 days around the LP from national data of 199 cases;
specificity was 78.8% based on our single-unit analysis.
Conclusions: Proposing a universal CRP > 10mg/L cut-off for a lumbar puncture has been counter-productive in
England. Following it generates significantly more LPs, to the point that 40.7% of trusts have chosen not to follow
it. It also has poor sensitivity missing over 11% of meningitis. We therefore do not recommend a universal cut-off,
rather considering the whole clinical picture (including prematurity) when considering whether to do an LP.
Keywords: meningitis, neonatal, CG149, C-reactive protein, CRP, cut-off, neonatal meningitis, lumbar puncture,
cerebrospinal fluid
Background
Neonatal meningitis is a potentially serious infection which
occurs in around 0.25 – 1.0 per 1000 live births [1, 2]. Al-
though the case-fatality rate of neonatal meningitis has
fallen to around 6.6% for all-cause meningitis [1] or 12.4%
for GBS meningitis [3], the morbidity associated with the
disease remains unchanged over the last 30 years [2, 4].
A lumbar puncture (LP) is required to investigate for men-
ingitis by sampling cerebrospinal fluid (CSF) for microscopy,
bacterial culture, and protein and glucose levels. The deci-
sion of when to perform an LP in a neonate can be a difficult
one. For those with early onset sepsis (usually <72h old), the
American Academy of Pediatrics (AAP) recommend per-
forming an LP if the blood culture is positive, the ‘clinical
course or laboratory data strongly suspect bacterial sepsis’, or
if the infant does not respond to antimicrobial therapy [5].
In England and Wales, the National Institute for Health and
Care Excellence (NICE) have published CG149 guidance
suggesting an LP be ‘considered’ if the blood culture is posi-
tive, the baby does not respond to antimicrobial therapy, or
if the baby has a ‘C-reactive protein concentration of 10 mg/
litre or greater’ [6]. This decision to name a specific cut-off
CRP of 10mg/L has been criticised by some, with a previous
study carried out in 2014 finding that when only the 59 re-
gional referral neonatal units were examined just 14% (10/
56) of them followed this CRP guidance [7].* Correspondence: jonathan.sturgeon@nhs.net
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This study therefore aimed to determine the compliance
of all neonatal units in England with this NICE CG149
guidance, the number of LPs performed and the number of
neonatal meningitis cases seen, as well as the CRP levels
seen in these cases in order to estimate a sensitivity for a
CRP cut-off of 10mg/L in neonatal meningitis. A recent
evaluation of all the lumbar punctures performed at our
local unit (Kingston Hospital, London) is also included.
Methods
Assessment of national picture of neonatal meningitis for
all NHS trusts across England
A list of all 137 NHS trusts at which a birth had taken
place in England in the most recent maternity report
was obtained from NHS Digital [8]. Requests were made
under the Freedom of Information Act (2000).
CRP Level for lumbar puncture
Each trust was asked for their neonatal sepsis and lumbar
puncture protocol as of 13/2/2018, and whether there was
a specific CRP which would warrant a lumbar puncture.
Responses were assessed as to whether any ‘consideration’
was given to a lumbar puncture because the CRP was
>10mg/L, and whether there were any additional levels
stated at which a lumbar puncture should be done. If dif-
ferent numbers for different hospitals in the same trust
were given, the highest number was captured.
Lumbar puncture and meningitis incidence
For the period between 01/10/2015 (when some ICD10
codes were changed) and 31/3/2018 each trust was
asked for the number of episodes with Z38.*, represent-
ing any live birth by any mode of delivery, the number
of these which also had a lumbar puncture procedure
code A55.9, and finally which of these received a G00.*,
G01.*, G02.*, or G03.* code for meningitis.
Maximal CRP in meningitis
Each trust that had >5 episodes of neonatal meningitis
was asked to provide the highest CRP level seen in the 4
days before or 4 days after the positive lumbar puncture
for each patient (defined as culture positive, WCC > 20/
mm3, or PCR positive) – only providing a result if there
were a positive CSF.
Assessment of local lumbar puncture results at Kingston
Hospital
Every CSF sample received from the neonatal or
post-natal wards at Kingston Hospital by the laboratory
between 15/12/2014 – 31/1/2018 was included. Kingston
rigidly interpreted the NICE CG149 guidelines, with the
trust’s guidelines introduced in June 2013, aiming to per-
form an LP on every neonate with a CRP > 10mg/L, as
well as if any positive culture or clinical concern.
The CSF protein, glucose, cell count, and CSF culture
result were noted, as well as the maximal blood CRP in
the first three days after starting antibiotics, and blood
culture result. The baby’s age and gestation were also
noted. A lumbar puncture was considered culture posi-
tive if the CSF grew an organism, and ‘cell count’ posi-
tive if there were more than 20 WCC/mL in the CSF
sample.
Data analysis
Data were analysed using SPSS (v24, IBM Corp); graphs
were prepared using Graphpad Prism (v7.0c, Graphpad
software); trusts were mapped using Tableau Desktop
(v10.5, Tableau Software). Groups were compared using
Mann-Whitney U test with significance being considered
at p<0.05, having confirmed the data was not normally
distributed.
Results
National data
Out of the 137 trusts listed in England that recorded a
birth in 2016-7, because of three mergers and two trusts
only providing community care with no inpatient facil-
ities, at the time of the requests there were 132 trusts
that could provide treatment to a potentially sick neo-
nate. All were successfully contacted to request the de-
sired information.
CRP level for lumbar puncture
A total of 123/132 (93.2%) of trusts responded. 73/123
(59.3%) of trusts gave some degree of consideration to a
lumbar puncture when the CRP was over 10mg/L, there-
fore directly following the NICE CG149 guidelines. The
remainder either did not give any CRP value – leaving
the decision for a lumbar puncture up to treating clin-
ician (20/123, 16.3%), or gave a higher CRP level at
which lumbar punctures would be considered (30/123,
24.4%, range 20 – 50 mg/L, median 20mg/L). Data
shown on the map in Fig. 1.
Of the 73 trusts that did give some form of consider-
ation to an LP with a CRP of >10mg/L, 32 gave a further
de facto higher level for babies who were asymptomatic,
usually on the postnatal ward (range 20 – 60 mg/L, me-
dian 20mg/L).
Lumbar puncture and meningitis rates
101/132 trusts (76.5%) provided full data on lumbar
punctures and meningitis rates. On top of this, eight
trusts provided their number of cases of meningitis in
the period as ‘under five’ over concerns over identifica-
tion of patients, and three trusts inadvertently provided
the diagnosis code of A55.9, rather than the procedure
code, and did not respond to requests to correct it.
These data were excluded from analysis. There were
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1,233,485 live births between 1/10/15 and 31/3/18. Of
these 16,963 (1.37%) also received a lumbar puncture
coding, and 576 also received a meningitis diagnosis in
the same episode, representing a nationwide incidence
of 0.467/1000 live births. Trusts considering an LP at
CRP > 10mg/L carry out a significantly higher number
of LPs compared with trusts that do not specifically
mention this cut-off (median 1.07%, IQR 0.65 – 2.3%, of
live births v 0.85%, IQR 0.34 – 1.31%, p=0.042), without
a corresponding significant increase in meningitis cases
(0.27/1,000 live births, IQR 0.00 – 0.87, v 0.20/1,000,
IQR 0.04 – 0.64, p=0.54), as shown in Fig. 2.
CRP rises in neonates with meningitis
CRP levels were provided for 199 cases of neonatal
meningitis out of a possible 393 cases, representing a
response rate of 50.6% of cases from trusts with over
5 cases. The mean maximum CRP was 56.7mg/L,
with 22 cases (11.1%) having a maximum CRP level
of <10mg/L in their meningitis infection; this repre-
sents a sensitivity of 88.9% for that cut-off in all
neonatal meningitis. The breakdown of the maximum
CRPs seen is shown in Fig. 3.
Local (Kingston Hospital) lumbar puncture data
511 CSF samples were sent from the neonatal unit or
postnatal ward at Kingston Hospital between 15/12/2014
– 31/01/2018. There was an LP frequency of 2.76% of
live births. The mean maximal CRP seen in the babies
was 36.9mg/L. The breakdown of all LPs by neonatal
maximal CRP are shown in Fig. 4.
There were 12 CSF samples that were positive on bac-
terial culture, 11 of these were commensal organisms
and on consideration of the whole clinical picture of the
baby the attending physician considered them contami-
nants. The culture-positive CSF sample was Enterobacte-
riaceae growth in a premature baby who had a
maximum CRP of < 10 mg/L, with the LP done because
they also grew the same organism in their blood culture.
A total of 224 samples were also tested for virology, and
1 was positive with an enterovirus with a maximal CRP
of between 20 - 29.9 mg/L.
Fig. 1 Map of England showing the trusts which consider a neonatal LP at CRP > 10mg/L, as well as the maximum CRP cut-off for an
LP mentioned in their protocol. Map background © OpenStreetMap contributors, and is reproduced under the Open Database Licence;
information is available from openstreetmap.org
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Four further babies were treated as meningitis because
of a significant pleocytosis, with a white cell rise to >20/
mm3 in the CSF. Two additional cases of mild pleocyto-
sis (20-35/mm3) were considered by the attending phys-
ician to be because of a traumatic tap, and were not
treated as meningitis.
There were 2273 incidences of babies being screened
and treated for sepsis, making them potentially eligible
for an LP. As no baby with CRP <10mg/L was subse-
quently re-admitted with a positive CSF, it is reasonable
to assume they are likely not to have had meningitis.
With this assumption, this represents a local specificity
for the CRP >10mg/L cut-off of 78.8%. The local positive
predictive value (PPV) of CRP > 10mg/L cut-off was
1.0% overall, but broken down was 0.4% for babies over
37 weeks’ gestation, and 5.6% for pre-term babies.
Discussion
This study looked at the adoption of the NICE CG149
CRP >10mg/L cut-off for considering an LP in neonatal
units in England, the number of LPs and cases of neo-
natal meningitis diagnosed, the CRP rises seen in these
cases, as well as the breakdown of all neonatal LPs per-
formed at our local unit.
The observed neonatal meningitis incidence rate of
0.467/1,000 live births fits well with the 0.25 – 1.0/1,000
values already reported in the literature [2]. The national
neonatal LP rate of 1.37% is slightly lower than the 1.7%
previously quoted from a single-centred study from
1995, [9] which was before the introduction of the 2012
CG149 guideline, and lower than the Kingston LP inci-
dence of 2.76% which rigidly used a CRP >10mg/L
cut-off. This suggests following the release of the CG149
A B
Fig. 2 Graphs showing a the number of LPs done per 1000 live births by trust and b the number of meningitis cases diagnosed per 1000 live
births. Each dot represents an individual trust, separated in to trusts which consider a lumbar puncture (LP) at CRP >10mg/L or not. The bars
represent the median values. * = p<0.05
Fig. 3 The maximal CRP levels seen in cases of neonatal meningitis,
using the national data
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guideline, the number of LPs had not increased, perhaps
reflecting the level of its adoption.
Only 59.3% of the 123 local trusts who responded have
guidelines that specifically follow the NICE CG149 CRP
>10mg/L cut-off for ‘considering’ an LP in a neonate, with
the remainder either not having a level, or having a higher
cut-off. The CRP level is just one of the three NICE
CG149 criteria for consideration of an LP, but because of
the low incidence of either positive blood cultures [10] or
poor response to antibiotics, it is the criteria that most
considerations for an LP would fall under. Several trusts
expand in their protocol why their CRP cut-off does not
follow the national guidance, with one trust simply putting
‘it has been admitted this number is not evidence based’,
another saying it was ‘too low’, and there has been con-
cerns that adopting the CRP cut-off increases the number
of LPs done [11]. This is seen in this study in the signifi-
cantly higher rate of LPs done in trusts who have adopted
the CG149 CRP criteria in their protocols.
When looking at their explanation for why they chose
a CRP < 10mg/L cut-off for an LP, the NICE guideline
development group (GDG) based their CRP > 10mg/L
recommendation looking at evidence of CRP rises seen
in neonatal sepsis. For a sepsis diagnosis their evidence
looked at different CRP cut-offs from 2.5mg/L [12] to
10mg/L [13] for diagnosis of sepsis in babies aged under
12 hours [12] to up to 10 days old [14], therefore making
their final recommendation based on the increased like-
lihood of sepsis rather than specifically meningitis. The
GDG were no doubt considering that in bacteraemic
infants, the meningitis incidence can be as high as 23%
[15, 16].
However, CRP rises do not necessarily mean bacteraemia,
and vice-versa. CRP responses in neonatal infection are
heterogenous: CRP synthesis is delayed during the early in-
flammatory response therefore CRP has low sensitivity dur-
ing early phases of the disease, necessitating repeat
measurements [17]. Severity of illness, hypoxia, prematur-
ity, and co-morbidities can all blunt a CRP response [18].
In addition, the CRP can also rise secondary to
non-infective conditions including respiratory distress syn-
drome, meconium aspiration syndrome, stressful delivery,
perinatal asphyxia or intraventricular haemorrhage [19]
meaning it is poorly specific. Although CRP cannot cross
the placenta, maternal pro-inflammatory cytokines such as
IL-6 can cross the placenta, potentially inducing CRP pro-
duction in the neonate [20]. Consequently, studies have
shown that maternal fever and prolonged labour can
increase CRP in uninfected neonates [21]. These
non-infectious rises can be significant – one study of 859
well neonates showed a mean CRP rise to 4.1mg/L by 48
hours, with the 95% centile of the results rising to 13.3mg/
L [22].
Because of the low incidence of neonatal meningitis,
few studies have been done on the CRP rises in neonatal
meningitis, and those done have small numbers: the sen-
sitivity of a CRP > 10mg/L cut-off has been suggested to
be 76.3% in one study, [23] and a CRP > 40mg/L to be
72.7% at 24h [24]. This study is therefore able to add a
significant body of data representing the CRP rises in
Fig. 4 Graph showing the maximal CRP levels seen in those babies who had a lumbar puncture (LP) at Kingston Hospital, along with the cases
that had meningitis
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neonatal meningitis with a positive CSF (either culture
positive, WCC > 20/mm3, or PCR positive), with poor
sensitivity and specificity for a CRP > 10mg/L cut-off.
Being the highest recorded CRP value 4 days around the
positive LP, the timings of the CRPs in this study do not
match the initial and 18-24h timings of the NICE
CG149 guideline. This wider timeframe was chosen to
ensure the highest CRP rise was captured when an LP
could have been done at any time during the course of
the illness. If the CRP rise could have been restricted to
the CG149 initial and 18-24h repeat values of the septic
episode, the sensitivity is likely to have been even lower.
Limitations of this study are related to how the data
was obtained, through Freedom of Information Act
(2000) requests. As well as the administrative burden it
places on trusts, no personally identifiable information
could be obtained, so information such as the neonate’s
gestation could not be requested. Gestation is signifi-
cant with neonatal sepsis: premature babies below 33
weeks’ gestation, and low-weight infants are more likely
to get infections, [1] and their CRP rises are likely to be
less. Reflecting the likely different response to meningi-
tis in term babies, several one-centre reports [25–27] as
well as one review question, [28] suggest no asymptom-
atic term baby had meningitis regardless of CRP level.
This is reflected in our local results with the CRP >
10mg/L cut-off demonstrating a significantly lower PPV
at 0.4% for term babies, but 5.6% for pre-term babies.
Finally, because Hospital Episode Statistics were used
to identify cases of neonatal meningitis, and each case
required a Z38.* birth code given once only, any neo-
nate who had meningitis after discharge or transfer
would not be included.
Finally, because there is no coding differentiation be-
tween early- and late-onset sepsis meningitis, both are
included in this study. Although the organisms causing
late-onset sepsis may be different, CRP responses in
early- and late- onset sepsis are similar with potentially
more sensitivity for sepsis in late-onset sepsis [29].
Conclusions
With the dissimilar causes and responses of CRP rises
in different-gestation neonates, and the lack of evi-
dence of CRP changes in neonatal meningitis, it is
easy to see why the AAP did not recommend a
laboratory-marker cut-off for doing an LP [5]. The
NICE GDG may well have been attempting to ensure
all neonates with meningitis were included by select-
ing a specific CRP for their LP criteria. Recognising
these criteria were poorly specific they included the
instruction to only ‘consider’ an LP if CRP > 10mg/L
or one of the other criteria were filled – allowing for
physician discretion to reduce unnecessary LPs. This
approach has practically been counter-productive
when considering its adoption, on both sensitivity and
specificity grounds. Because physician discretion is
not conducive to black-and-white instructions on
local protocols, 40.7% trusts have not adopted it pre-
sumably due to the number of LPs it would require
given the test’s low specificity on the background of
low-incidence disease. It also fails to include 11.1% of
neonatal meningitis cases. Because of both of these
failures, it does not seem prudent to assign a univer-
sal CRP cut-off for consideration of an LP, rather the
decision should be multi-faceted taking in to account
the gestation, clinical assessment, microbiology re-
sults, strength of concern, as well as any blood results
such as CRP.
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